Metformin plays an important role in tumour-associated fibroblasts, since it decreases the stimulatory effect of these cells on GC proliferation, impairing tumour growth through increasing calmodulin-like protein 3 secretion of tumour-associated fibroblasts. Here, CALML3 is linked to neoplasm.